참고문헌
- Chen, C.J., Kuo, T.L, Wu, M.M. Arsenic and cancers. Lancet 1, 414-415, 1988.
- Tseng, C,H,, Tseng, C,P., Chiou, H,Y., Hsueh, Y.M., Chong, C,K,, Chen, C,J.. Epidemiologic evidence of diabetogenic effect of arsenic. Toxicol. Lett. 133, 69-76, 2002.
- Ding, M., Shi, X., Castranova, V., Vallyathan, V. Predisposing factors in occupational lung cancer: inorganic minerals and chromium. J. Environ. Pathol. Toxicol. Oncol. 19, 129-138, 2000
- Murgo, A.J., McBee, W.L., Cheson, B.D. Clinical trials referral resource. Clinical trials with arsenic trioxide. Oncology (Huntingt) 14, 206, 211, 215-216, 2000.
- Hussein, M.A. Arsenic trioxide: a new immunomodulatory agent in the management of multiple myeloma. Med. Oncol. 18, 239-242, 2001.
- Soto, A.M., Sonnenschein, C. The somatic mutation theory of cancer: growing problems with the paradigm? Bioessays 26, 1097-1107, 2004.
- Arends, M.J., Morris, R.G., Wyllie, A.H. Apoptosis. The role of the endonuclease. Am. J. Pathol. 136, 593-608, 1990.
- Evans, V.G. Multiple pathways to apoptosis. Cell Biol. Int. 17, 461-476, 1993.
- Shi, L., Nishioka, W.K., Th'ng, J., Bradbury, E.M., Litchfield, D.W., Greenberg, A.H. Premature p34cdc2 activation required for apoptosis. Science 263, 1143-1145, 1994.
- Chiarugi, V., Magnelli, L., Basi, G. Apoptosis and the cell cycle. Cell. Mol. Biol. Res. 40, 603-612, 1994.
- Nagata, S. Apoptosis by death factor. Cell 88, 355-365, 1997.
-
Ahn, W.S., Bae, S.M., Lee, K.H., Kim, Y.W., Lee, J.M., Narnkoong, S.E., Lee, I.P., Kim, C.K., Seo, J.S., Sin, J.I., Kim, Y.W. Comparison of effects of
$As_2O_3$ and$As_4O_6$ on cell growth inhibition and gene expression profiles by eDNA microarray analysis in SiHa cells. Oncol. Rep. 12, 573-580, 2004. - Park, W.H, Seol, J.G., Kim, E.S., Hyun, J.M., Jung, C.W., Lee, C.C., Kim, B.K, Lee, Y.Y. Arsenic trioxide-mediated growth inhibition in MC,CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res. 60, 3065-3071, 2000.
- Hei, T.K., Filipic, M. Role of oxidative damage in the genotoxicity of arsenic. Free Radic. Biol. Med. 37, 574-581, 2004.
- Zhu, J., Okumura, H., Ohtake, S., Nakamura, S., Nakao, S. Arsenic trioxide induces apoptosis in leukemia,lymphoma cell lines via the CD95,CD95L system. Oncol. Rep. 10, 705-709, 2000.
- Park, I.C, Park, M.J., Woo, S.H, Lee, H.C., An, S., Gwak, H.S., Lee, S.H., Hong, S.I., Bae, I.J., Seo, KM., Rhee, C.H. Tetraarsenic oxide induces apoptosis in U937 leukemic cells through a reactive oxygen species-dependent pathway. Int. J. Oncol. 23, 943-948, 2003.
-
Maeda, H., Hori, S., Nishitoh, H., Ichijo, H., Ogawa, O., Kakehi, Y., Kakizuka, A Tumor growth inhibition by arsenic trioxide (
$As_2O_3$ ) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 61, 5432-5440, 2001. - Hernandez-Zavala, A., Cordova, E., Del Razo, L.M., Cebrian, M.E., Garrido, E. Effects of arsenite on cell cycle progression in a human bladder cancer cell line. Toxicology 207, 49-57, 2005.
- Lau, AT., Li, M., Xie, R., He, Q.Y., Chiu, J.F. Opposed arsenite-induced signaling pathways promote cell proliferation or apoptosis in cultured lung cells. Carcinogenesis 25, 21-28, 2004.
- Sordet, O., Liao, Z., Liu, H., Antony, S., Stevens, E. V., Kohlhagen, G., Fu, H., Pommier, Y. Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis. J. Biol. Chem. 279, 33968-33975, 2004.
- Zhang, T.C., Cao, E.H., Li, J.F., Ma, W., Qin, J.F. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur. J. Cancer 35, 1258-1263, 1999.
-
Chun, Y.J., Park, I.C., Park, M.J., Woo, S.H., Hong, S.I., Chung, H.Y., Kim, T.H., Lee, Y.S., Rhee, C.H., Lee, S.J. Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (
$As_2O_3$ ). FEBS Lett 519(1-3):195-200, 2002. - Zhang, Y., Shen, W.L. Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide. Cell Biol. Int. 27, 953-958, 2003.